1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration

Neuropsychopharmacology

Volumn 29, Issue 10, 2004, Pages 1918-1924

  Brambilla, Paolo ^a,b,c   Stanley, Jeffrey A ^d   Sassi, Roberto B ^d,e   Nicoletti, Mark A ^a   Mallinger, Alan G ^d,f   Keshavan, Matcheri S ^d   Soares, Jair C ^a,g  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Glutamate; Healthy individuals; Lithium; N acetyl aspartate; Prefrontal cortex; Proton magnetic resonance spectroscopy

Indexed keywords

CREATINE; CREATINE PHOSPHATE; GLYCEROPHOSPHORYLCHOLINE; INOSITOL; LITHIUM; N ACETYLASPARTIC ACID; PHOSPHORYLCHOLINE; ASPARTIC ACID; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; AMINO ACID BRAIN LEVEL; ARTICLE; BIPOLAR DISORDER; BRAIN LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NORMAL HUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ADOLESCENT; CHEMISTRY; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REFERENCE VALUE;

ADOLESCENT; ADULT; ASPARTIC ACID; FEMALE; HUMANS; LITHIUM; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PREFRONTAL CORTEX; REFERENCE VALUES;

EID: 5044227266     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300520     Document Type: Article

References (43)

1. Brambilla P, Barale F, Caverzasi E, Soares JC (2002b). Anatomical MRI findings in mood and anxiety disorders. Epidemiol Psychiatr Soc 11: 88-99.
2. Brambilla P, Barale F, Soares JC (2003). Atypical antipsychotics and mood stabilization in bipolar disorder. Psychopharmacology 166: 315-332.
3. Brambilla P, Stanley JA, Nicoletti M, Harenski K, Forster Wells K, Mallinger AG et al (2002a). H MRS brain measures and acute lorazepam administration in healthy human subjects. Neuropsychopharmacology 26: 546-551.
4. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH et al (1999). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72: 879-882.
5. Chen RW, Chuang DM (1999). Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 274: 6039-6042.
6. Chuang D-M, Chen R-W, Chaleka-Franaszek E, Ren M, Hashimoto R, Senatorov V et al (2002). Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord 4: 129-136.
7. 1H spectroscopic imaging data sets. NMR Biomed 5: 171-178.
8. Deicken RF, Calabrese G, Raz J, Sappey-Marinier D, Meyerhoff D, Dillon WP et al (1992). A 31 phosphorous magnetic resonance spectroscopy study of diazepam does not affect brain phosphorous metabolism. Biol Psychiatry 32: 628-631.
9. Deicken RF, Eliaz Y, Feiwell R, Schuff N (2001). Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Res: Neuroimaging 106: 35-45.
10. George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li X et al (2000). A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry 48: 962-970.
11. Heuser IJ, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M et al (1996). Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J Psychiatry 153: 93-99.
12. Jackson GD, Duncan JS (1996). MRI Anatomy: A New Angle on the Brain. Churchill Livingstone: New York.
13. Jope RS (1999). Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 4: 117-128.
14. Keshavan MS, Anderson S, Beckwith C, Nash K, Pettegrew JW, Krishnan KR (1995). A comparison of stereology and segmentation techniques for volumetric measurements of lateral ventricles in magnetic resonance imaging. Psychiatry Res 61: 53-60.
15. Keshavan MS, Beckwith W, Pettegrew W, Krishnan KR (1994). An objective method for edge detection in MRI morphometry. Eur Psychiatry 9: 205-207.
16. Lenox RH, Hahn C-G (2000). Overview of the mechanism of action of lithium in the brain: fifty-year update. J Clin Psychiatry 61: 5-15.
17. Lyoo IK, Kong SW, Sung SM, Hirashima F, Parow A, Hennen J et al (2003). Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate. Psychiatry Res 123: 87-100.
18. Manji HK, Moore GJ, Chen G (2000). Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in maniac depressive illness. J Clin Psychiatry 61: 82-96.
19. 1H NMR spectroscopy: N-acetyl-L-aspartate, creating and choline. NMR Biomed 4: 47-52.
20. Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB et al (2000a). Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 48: 1-8.
21. Moore GJ, Bebchuck JM, Wilds IB, Chen G, Manji HK (2000b). Lithium-induced increase in human brain gray matter. Lancet 356: 1241-1242.
22. Morice R (1990). Cognitive inflexibility and pre-frontal dysfunction in schizophrenia and mania. Br J Psychiatry 157: 50-54.
23. Nauta WJ (1971). The problem of the frontal lobe: a reinterpretation. J Psychiatr Res 8: 167-187.
24. Pouwels PJ, Frahm J (1998). Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 39: 53-60.
25. Quintana J, Fuster JM (1999). From perception to action: temporal integrative functions of prefrontal and parietal neurons. Cerebral Cortex 9: 213-221.
26. Rajkowska G, Halaris A, Selemon LD (2001). Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 49: 741-752.
27. Renshaw PF, Yurgelun-Todd DA, Tohen M, Gruber S, Cohen BM (1995). Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry 152: 444-446.
28. Sassi RB, Nicoletti M, Brambilla P, Mallinger AG, Fran E, Kupfer DJ et al (2002). Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett 329: 243-245.
29. Sax KW, Strakowski SM, Zimmerman ME, DelBello MP, Keck Jr PE, Hawkins JM (1999). Frontosubcortical neuroanatomy and the continuous performance test in mania. Am J Psychiatry 156: 139-141.
30. Sharma R, Venkatasubramanian PN, Barany M, Davis JM (1992). Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophren Res 8: 43-49.
31. 31P MRS. Biol Psychiatry 40: 235-246.
32. Silverstone PH, Hanstock CC, Rotzinger S (1999a). Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy. J Psychiatry Neurosci 24: 222-226.
33. 31P MRS. Biol Psychiatry 46: 1634-1641.
34. Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC (2003). Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacolgy 18: 73-79.
35. Soares JC, Gershon S (1998). The lithium ion: a foundation for psychopharmacological specificity. Neuropsychopharmacology 19: 167-182.
36. Soares JC, Mann JJ (1997). The functional neuroanatomy of mood disorders. J Psychiatr Res 31: 393-432.
37. Stanley JA (2002a). In vivo magnetic resonance spectroscopy and its application to neuropsychiatrie disorders. Canad J Psychiatry 47: 315-326.
38. 1H MR spectra. Magn Reson Med 34: 17-24.
39. 1H spectra Proc Int Soc Magn Reson Med (Berkeley CA), 2514.
40. Stanley JA, Pettegrew JW, Keshavan MS (2000). Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings-part I. Biol Psychiatry 48: 357-368.
41. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA (2000). Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 47: 475-481.
42. Yuh WTC, Tali ET, Afifi AK, Sahinoglu K, Gai F, Bergman RA (1994). MRI of Head & Neck Anatomy. Churchill Livingstone: New York.
43. Zanardi R, Racagni G, Smeraldi E, Perez J (1997). Differential effects of lithium on platelet protein phosphorylation in bipolar patients and healthy subjects. Psychopharmacology 129: 44-47.